BMS-707035

CAS No. 729607-74-3

BMS-707035 ( BMS 707035;BMS707035 )

Catalog No. M15791 CAS No. 729607-74-3

BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 88 In Stock
25MG 177 In Stock
50MG 324 In Stock
100MG 528 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS-707035
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
  • Description
    BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.HIV Infection Phase 2 Discontinued
  • Synonyms
    BMS 707035;BMS707035
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV-Iintegrase
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    729607-74-3
  • Formula Weight
    410.42
  • Molecular Formula
    C17H19FN4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    Cn1c(=O)c(c(nc1N2CCCCS2(=O)=O)C(=O)NCc3ccc(cc3)F)O
  • Chemical Name
    4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dicker IB, et al. J Biol Chem. 2007 Oct 26;282(43):31186-96.
2. Langley DR, et al. Biochemistry. 2008 Dec 23;47(51):13481-8.
3. Al-Mawsawi LQ, et al. Expert Opin Emerg Drugs. 2008 Jun;13(2):213-25.
molnova catalog
related products
  • PF-3450074

    PF-3450074 (PF74) is a small molecule HIV capsid protein, destabilized the viral capsid in vitro; acts at an early stage of HIV-1 infection and inhibits reverse transcription in target cells.

  • Abacavir

    A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.

  • 14-Dicaffeoylquinic ...

    14-Dicaffeoylquinic acid has antioxidant activity.14-Dicaffeoylquinic acid is a potent and highly selective class of HIV-1 integrase inhibitors inhibitsHIV-1 replication in MT-2 cell culture at non-toxic concentrations.